Neuronally Derived Extracellular Vesicle α-Synuclein as a Serum Biomarker for Individuals at Risk of Developing Parkinson Disease

快速眼动睡眠行为障碍 生物标志物 帕金森病 多巴胺转运体 嗅觉减退 内科学 医学 疾病 路易氏体型失智症 肿瘤科 心理学 痴呆 多巴胺 生物 多巴胺能 2019年冠状病毒病(COVID-19) 传染病(医学专业) 生物化学
作者
Shijun Yan,Cheng Jiang,Annette Janzen,Thomas R. Barber,Aline Seger,Michael Sommerauer,Jason J. Davis,Kenneth Marek,Michele Hu,Wolfgang H. Oertel,George K. Tofaris
出处
期刊:JAMA Neurology [American Medical Association]
卷期号:81 (1): 59-59 被引量:17
标识
DOI:10.1001/jamaneurol.2023.4398
摘要

IMPORTANCE Nonmotor symptoms of Parkinson disease (PD) often predate the movement disorder by decades. Currently, there is no blood biomarker to define this prodromal phase. OBJECTIVE To investigate whether α-synuclein in neuronally derived serum-extracellular vesicles identifies individuals at risk of developing PD and related dementia. DESIGN, SETTING, and PARTICIPANTS This retrospective, cross-sectional multicenter study of serum samples included the Oxford Discovery, Marburg, Cologne, and Parkinson’s Progression Markers Initiative cohorts. Participants were recruited from July 2013 through August 2023 and samples were analyzed from April 2022 through September 2023. The derivation group (n = 170) included participants with isolated rapid eye movement sleep behavior disorder (iRBD) and controls. Two validation groups were used: the first (n = 122) included participants with iRBD and controls and the second (n = 263) included nonmanifest GBA1 N409S gene carriers, participants with iRBD or hyposmia, and available dopamine transporter single-photon emission computed tomography, healthy controls, and patients with sporadic PD. Overall the study included 199 participants with iRBD, 20 hyposmic participants with available dopamine transporter single-photon emission computed tomography, 146 nonmanifest GBA1 N409S gene carriers, 21 GBA1 N409S gene carrier patients with PD, 50 patients with sporadic PD, and 140 healthy controls. In the derivation group and validation group 1, participants with polysomnographically confirmed iRBD were included. In the validation group 2, at-risk participants with available Movement Disorder Society prodromal markers and serum samples were included. Among 580 potential participants, 4 were excluded due to alternative diagnoses. EXPOSURES Clinical assessments, imaging, and serum collection. MAIN OUTCOME AND MEASURES L1CAM-positive extracellular vesicles (L1EV) were immunocaptured from serum. α-Synuclein and syntenin-1 were measured by electrochemiluminescence. Area under the receiver operating characteristic (ROC) curve (AUC) with 95% CIs evaluated biomarker performance. Probable prodromal PD was determined using the updated Movement Disorder Society research criteria. Multiple linear regression models assessed the association between L1EV α-synuclein and prodromal markers. RESULTS Among 576 participants included, the mean (SD) age was 64.30 (8.27) years, 394 were male (68.4%), and 182 were female (31.6%). A derived threshold of serum L1EV α-synuclein distinguished participants with iRBD from controls (AUC = 0.91; 95% CI, 0.86-0.96) and those with more than 80% probability of having prodromal PD from participants with less than 5% probability (AUC = 0.80; 95% CI, 0.71-0.89). Subgroup analyses revealed that specific combinations of prodromal markers were associated with increased L1EV α-synuclein levels. Across all cohorts, L1EV α-synuclein differentiated participants with more than 80% probability of having prodromal PD from current and historic healthy control populations (AUC = 0.90; 95% CI, 0.87-0.93), irrespective of initial diagnosis. L1EV α-synuclein was increased in at-risk participants with a positive cerebrospinal fluid seed amplification assay and was above the identified threshold in 80% of cases (n = 40) that phenoconverted to PD or related dementia. CONCLUSIONS AND RELEVANCE L1EV α-synuclein in combination with prodromal markers should be considered in the stratification of those at high risk of developing PD and related Lewy body diseases.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
美满的皮卡丘完成签到 ,获得积分10
3秒前
最美夕阳红完成签到,获得积分10
10秒前
六等于三二一完成签到 ,获得积分10
11秒前
wujiwuhui完成签到 ,获得积分10
14秒前
isedu完成签到,获得积分10
16秒前
叶痕TNT完成签到 ,获得积分10
17秒前
斜玉完成签到,获得积分10
17秒前
21GolDiamond完成签到,获得积分10
17秒前
鞑靼完成签到 ,获得积分10
21秒前
邵翎365完成签到,获得积分10
28秒前
zenabia完成签到 ,获得积分10
28秒前
闪闪的谷梦完成签到 ,获得积分10
30秒前
21完成签到 ,获得积分10
37秒前
俊逸吐司完成签到 ,获得积分10
38秒前
twelveyears完成签到 ,获得积分10
45秒前
风起枫落完成签到 ,获得积分10
56秒前
wenhuanwenxian完成签到 ,获得积分10
59秒前
jiayoujijin完成签到 ,获得积分10
1分钟前
Dingz完成签到,获得积分10
1分钟前
kumo完成签到 ,获得积分10
1分钟前
十七完成签到 ,获得积分10
1分钟前
求知若渴口好干完成签到 ,获得积分10
1分钟前
yinhe完成签到 ,获得积分10
1分钟前
无极2023完成签到 ,获得积分10
1分钟前
huangzsdy完成签到,获得积分10
1分钟前
微卫星不稳定完成签到 ,获得积分0
1分钟前
水星完成签到 ,获得积分10
1分钟前
客官们帮帮忙完成签到 ,获得积分10
1分钟前
loren313完成签到,获得积分0
1分钟前
陈大侠完成签到 ,获得积分10
1分钟前
jue完成签到 ,获得积分10
2分钟前
拉长的诗蕊完成签到,获得积分10
2分钟前
652183758完成签到 ,获得积分10
2分钟前
2分钟前
如意的馒头完成签到 ,获得积分10
2分钟前
泌尿小周完成签到 ,获得积分10
2分钟前
斯文的迎松完成签到,获得积分20
2分钟前
zx完成签到 ,获得积分10
2分钟前
爆米花应助john采纳,获得10
2分钟前
mjf111发布了新的文献求助10
3分钟前
高分求助中
Sustainability in Tides Chemistry 2000
Microlepidoptera Palaearctica, Volumes 1 and 3 - 13 (12-Volume Set) [German] 1122
Дружба 友好报 (1957-1958) 1000
The Data Economy: Tools and Applications 1000
Mantiden - Faszinierende Lauerjäger – Buch gebraucht kaufen 700
PraxisRatgeber Mantiden., faszinierende Lauerjäger. – Buch gebraucht kaufe 700
A Dissection Guide & Atlas to the Rabbit 600
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 基因 遗传学 催化作用 物理化学 免疫学 量子力学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 3099800
求助须知:如何正确求助?哪些是违规求助? 2751277
关于积分的说明 7612198
捐赠科研通 2403062
什么是DOI,文献DOI怎么找? 1275162
科研通“疑难数据库(出版商)”最低求助积分说明 616276
版权声明 599053